Immunoadsorption to treat patients with severe post-COVID syndrome.

Benjamin Giszas Philipp Alexander Reuken Katrin Claudia KatzerMichael KiehntopfDiana SchmerlerSilke RummlerAndreas Stallmach Anne Klink

Published in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2023)

Collectively, AAbs may play a pathophysiologic role in post-COVID and their removal provide transient benefits in some patients. However, these findings should be further investigated in randomized-controlled-trials.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
randomized controlled trial
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
systematic review
clinical trial
mass spectrometry
brain injury
single molecule
drug induced
meta analyses